Literature DB >> 8080448

Scavenging of reactive oxygen species by silibinin dihemisuccinate.

L Mira1, M Silva, C F Manso.   

Abstract

Silibinin dihemisuccinate (SDH) is a flavonoid of plant origin with hepatoprotective effects which have been partially attributed to its ability to scavenge oxygen free radicals. In the present paper the antioxidant properties of SDH were evaluated by studying the ability of this drug to react with relevant biological oxidants such as superoxide anion radical (O2-), hydrogen peroxide (H2O2), hydroxyl radical (HO.) and hypochlorous acid (HOCl). In addition, its effect on lipid peroxidation was investigated. SDH is not a good scavenger of O2- and no reaction with H2O2 was detected within the sensitivity limit of our assay. However, it reacts rapidly with HO. radicals in free solution at approximately diffusion-controlled rate (K = (1.0-1.2) x 10(10)/M/sec) and appears to be a weak iron ion chelator. SDH at concentrations in the micromolar range protected alpha 1-antiproteinase against inactivation by HOCl, showing that it is a potent scavenger of this oxidizing species. Luminol-dependent chemiluminescence induced by HOCl was also inhibited by SDH. The reaction of SDH with HOCl was monitored by the modification of the UV-visible spectrum of SDH. The studies on rat liver microsome lipid peroxidation induced by Fe(III)/ascorbate showed that SDH has an inhibitory effect, which is dependent on its concentration and the magnitude of lipid peroxidation. This work supports the reactive oxygen species scavenger action ascribed to SDH.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8080448     DOI: 10.1016/0006-2952(94)90053-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  20 in total

Review 1.  Phenylpropanoids in radioregulation: double edged sword.

Authors:  Wanyeon Kim; Ki Moon Seong; BuHyun Youn
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

Review 2.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

Review 3.  The use of silymarin in the treatment of liver diseases.

Authors:  R Saller; R Meier; R Brignoli
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Comparison of the prophylactic effect of silymarin and deferoxamine on iron overload-induced hepatotoxicity in rat.

Authors:  Hossein Najafzadeh; Mohammad Razi Jalali; Hassan Morovvati; Farnaz Taravati
Journal:  J Med Toxicol       Date:  2010-03

5.  A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories.

Authors:  B M Berkson
Journal:  Med Klin (Munich)       Date:  1999-10-15

6.  Assessment of the Antioxidant Activity of Silybum marianum Seed Extract and Its Protective Effect against DNA Oxidation, Protein Damage and Lipid Peroxidation.

Authors:  Aynur Serçe; Bircan Çeken Toptancı; Sevil Emen Tanrıkut; Sevcan Altaş; Göksel Kızıl; Süleyman Kızıl; Murat Kızıl
Journal:  Food Technol Biotechnol       Date:  2016-12       Impact factor: 3.918

7.  Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids.

Authors:  Hyoung-Woo Bai; Bao Ting Zhu
Journal:  J Lipid Res       Date:  2008-07-26       Impact factor: 5.922

Review 8.  Polyphenols and gastrointestinal diseases.

Authors:  Gerald W Dryden; Ming Song; Craig McClain
Journal:  Curr Opin Gastroenterol       Date:  2006-03       Impact factor: 3.287

9.  Influence of the metabolic profile on the in vivo antioxidant activity of quercetin under a low dosage oral regimen in rats.

Authors:  M R Santos; M J Rodríguez-Gómez; G C Justino; N Charro; M H Florencio; L Mira
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

10.  Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats.

Authors:  Pragada Rajeswara Rao; Routhu Kasi Viswanath
Journal:  Exp Clin Cardiol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.